Invacare Corporation Announces President and Chief Operating Officer Gerald Blouch...

Invacare Corporation Announces President and Chief Operating Officer Gerald Blouch as Interim Chief Financial Officer

ELYRIA, Ohio--(Business Wire)--Invacare Corporation (NYSE: IVC) today announced that chief
financial officer, Gregory Thompson, has informed the Company of his
decision to leave the Company for another opportunity. Mr. Thompson
has agreed to continue on in his current capacity through March 1st,
at which time Gerald Blouch, president and chief operating officer,
will assume the additional responsibilities as acting chief financial
officer.

Mr. Blouch joined Invacare in 1990 as chief financial officer. He
became chief operating officer in 1993 and later was named president
as well. Beginning immediately, Invacare will undertake a search for
candidates to assume the role of chief financial officer on a
permanent basis.

"We wish Greg well and thank him for his contributions to the
success of our Company," said A. Malachi Mixon, III, chairman and
chief executive officer of Invacare Corporation. "We are sure he will
be successful in his new endeavor."

The Company also reaffirmed its guidance for the year of adjusted
earnings per share(a) of $1.15 to $1.25, which includes a third
quarter one-time German tax benefit of $0.20 per share. The normal
quarterly conference call will be held no later than the week of
February 4th with Messrs. Mixon, Thompson and Blouch in attendance.

(a)Adjusted earnings per share is a non-GAAP financial measure
which is defined as net earnings excluding the impact of restructuring
charges and debt finance charges, interest and fees associated with
the Company's debt refinancing divided by weighted average shares
outstanding - assuming dilution.

Invacare Corporation (NYSE: IVC), headquartered in Elyria, Ohio,
is the global leader in the manufacture and distribution of innovative
home and long-term care medical products that promote recovery and
active lifestyles. The company has 5,700 associates and markets its
products in 80 countries around the world. For more information about
the company and its products, visit Invacare website at
www.invacare.com.

This press release contains forward-looking statements within the
meaning of the "Safe Harbor" provisions of the Private Securities
Litigation Reform Act of 1995. Terms such as "will," "should," "plan,"
"intend," "expect," "continue," "forecast"," believe," "anticipate"
and "seek," as well as similar comments, are forward-looking in
nature. Actual results and events may differ significantly from those
expressed or anticipated as a result of risks and uncertainties which
include, but are not limited to, the following: possible adverse
effects of being substantially leveraged, which could impact our
ability to raise capital, limit our ability to react to changes in the
economy or our industry or expose us to interest rate or event of
default risks; changes in government and other third-party payer
reimbursement levels and practices; consolidation of health care
providers and our competitors; loss of key health care providers;
ineffective cost reduction and restructuring efforts; inability to
design, manufacture, distribute and achieve market acceptance of new
products with higher functionality and lower costs; extensive
government regulation of our products; lower cost imports; increased
freight costs; failure to comply with regulatory requirements or
receive regulatory clearance or approval for our products or
operations in the United States or abroad; potential product recalls;
uncollectible accounts receivable; difficulties in implementing a new
Enterprise Resource Planning system; legal actions or regulatory
proceedings and governmental investigations; product liability claims;
inadequate patents or other intellectual property protection;
incorrect assumptions concerning demographic trends that impact the
market for our products; provisions in our bank credit agreement or
other debt instruments that may prevent or delay a change in control;
the loss of the services of our key management and personnel;
decreased availability or increased costs of raw materials which could
increase our costs of producing our products; inability to acquire
strategic acquisition candidates because of limited financing
alternatives; risks inherent in managing and operating businesses in
many different foreign jurisdictions; exchange rate fluctuations, as
well as the risks described from time to time in Invacare's reports as
filed with the Securities and Exchange Commission. Except to the
extent required by law, we do not undertake and specifically decline
any obligation to review or update any forward-looking statements or
to publicly announce the results of any revisions to any of such
statements to reflect future events or developments or otherwise.

Invacare Corporation
Investor Inquiries:
Greg Thompson, 440-329-6111

Copyright Business Wire 2008